{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:37:31Z","timestamp":1777631851773,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.gene.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T17:01:06Z","timestamp":1520096466000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"657","author":[{"given":"Jun-lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-bei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-kai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.03.007_bb0005","first-page":"343","article-title":"Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis","volume":"d4588","author":"Bauer","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.gene.2018.03.007_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2018.03.007_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.0000085073.69189.88","article-title":"Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects","volume":"108","author":"Fontana","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2018.03.007_bb0025","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","volume":"61","author":"Frelinger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0030","first-page":"491","article-title":"P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation","volume":"37","author":"Galic","year":"2013","journal-title":"Coll. Anthropol."},{"key":"10.1016\/j.gene.2018.03.007_bb0035","article-title":"Does i-T744C P2Y12 polymorphism modulate Clopidogrel response among Moroccan acute coronary syndromes patients?","volume":"2017","author":"Hassani Idrissi","year":"2017","journal-title":"Genet. Res. Int."},{"key":"10.1016\/j.gene.2018.03.007_bb0040","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","article-title":"Purinergic receptors in thrombosis and inflammation","volume":"35","author":"Hechler","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2018.03.007_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jacc.2009.12.071","article-title":"Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis","volume":"56","author":"Hulot","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjcard.2012.04.020","article-title":"Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel","volume":"110","author":"Jang","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0055","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.03.007_bb0060","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11033-010-0282-0","article-title":"Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel","volume":"38","author":"Jin","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2018.03.007_bb0065","series-title":"China Pharmacy","first-page":"2983","article-title":"Association of P2Y1, P2Y12 and ITGB3 genetic polymorphisms with the antiplatelet efficacy of aspirin and clopidogrel after PCI","volume":"25","author":"Lai","year":"2014"},{"key":"10.1016\/j.gene.2018.03.007_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5482\/HAMO-16-03-0010","article-title":"Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders","volume":"36","author":"Lecchi","year":"2016","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.gene.2018.03.007_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2005.08.058","article-title":"Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance","volume":"47","author":"Lev","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0080","first-page":"333","article-title":"Association between clopidogrel resistance and polymorphism of platelet adenosine diphosphate receptor in patients with coronary atherosclerotic disease","volume":"43","author":"Li","year":"2014","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.gene.2018.03.007_bb0085","article-title":"Association of PON1, P2Y12 and COX1 with recurrent ischemic events in patients with extracranial or intracranial stenting","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.03.007_bb0090","article-title":"Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.gene.2018.03.007_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4244\/EIJV9I3A53","article-title":"The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation","volume":"9","author":"Liang","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.gene.2018.03.007_bb0100","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4103\/0366-6999.162515","article-title":"CYP2C19*2 and other allelic variants affecting platelet response to clopidogrel tested by thrombelastography in patients with acute coronary syndrome","volume":"128","author":"Liu","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.gene.2018.03.007_bb0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1253\/circj.72.1165","article-title":"Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel","volume":"72","author":"Malek","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.gene.2018.03.007_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.acvd.2013.06.055","article-title":"Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects","volume":"106","author":"Mao","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.gene.2018.03.007_bb0115","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gene.2018.03.007_bb0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1631\/jzus.B1600333","article-title":"Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity","volume":"18","author":"Nie","year":"2017","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.gene.2018.03.007_bb0130","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1253\/circj.CJ-12-0476","article-title":"Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in Japanese patients receiving clopidogrel","volume":"76","author":"Nishio","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.gene.2018.03.007_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11596-015-1404-7","article-title":"CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: a systematic review and meta-analysis","volume":"35","author":"Niu","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.gene.2018.03.007_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/hrt.2011.227272","article-title":"Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents","volume":"98","author":"Oh","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.gene.2018.03.007_bb0145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1536\/ihj.16-006","article-title":"Genotype frequencies of CYP2C19, P2Y(12) and GPIIIa polymorphisms in coronary heart disease patients of Han ethnicity, and their impact on clopidogrel responsiveness","volume":"57","author":"Ou","year":"2016","journal-title":"Int. Heart J."},{"key":"10.1016\/j.gene.2018.03.007_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2018.03.007_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/jhg.2013.41","article-title":"Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?","volume":"58","author":"Perry","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.03.007_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/humu.20641","article-title":"Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions","volume":"29","author":"Rudez","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2018.03.007_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCGENETICS.109.861799","article-title":"Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions","volume":"2","author":"Rudez","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.gene.2018.03.007_bb0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2006.01789.x","article-title":"P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1\/2 activation","volume":"4","author":"Shankar","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.gene.2018.03.007_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000457947","article-title":"Genotyping, platelet activation, and cardiovascular outcome in patients after percutaneous coronary intervention: two pieces of the puzzle of clopidogrel resistance","volume":"137","author":"Siasos","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.gene.2018.03.007_bb0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2018.03.007_bb0185","first-page":"841","article-title":"Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gene.2018.03.007_bb0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijcard.2007.12.118","article-title":"Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene","volume":"133","author":"Staritz","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.gene.2018.03.007_bb0195","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.4238\/2015.February.13.22","article-title":"Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients","volume":"14","author":"Sun","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2018.03.007_bb0200","first-page":"1283","article-title":"Association between P2Y12 platelet receptor (C34T and G52T) polymorphisms and risk of cardiovascular events in coronary heart disease with clopidogrel in Chinese","volume":"5","author":"Tang","year":"2011","journal-title":"Chin J Clinicians"},{"key":"10.1016\/j.gene.2018.03.007_bb0205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3760\/cma.j.issn.0366-6999.20123360","article-title":"Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention","volume":"126","author":"Tang","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.gene.2018.03.007_bb0210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/gtmb.2014.0077","article-title":"Genetic polymorphisms of platelet receptors in patients with acute myocardial infarction and resistance to antiplatelet therapy","volume":"18","author":"Ulehlova","year":"2014","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.gene.2018.03.007_bb0215","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcin.2013.06.010","article-title":"Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease","volume":"6","author":"Viviani Anselmi","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.gene.2018.03.007_bb0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1735-1995.193502","article-title":"Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: a cohort study from Han Chinese","volume":"21","author":"Wang","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.gene.2018.03.007_bb0225","series-title":"3rd Symposium on Systematic Reviews: Beyond the Basics; 2000 Jul 3\u20135; Oxford, UK","first-page":"15","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [abstract]","author":"Wells","year":"2000"},{"key":"10.1016\/j.gene.2018.03.007_bb0230","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","article-title":"ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels","volume":"24","author":"Wihlborg","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2018.03.007_bb0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09537104.2012.700969","article-title":"Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: a systematic review and meta-analysis","volume":"24","author":"Yamaguchi","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.gene.2018.03.007_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.atherosclerosis.2007.07.001","article-title":"Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism","author":"Zee","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2018.03.007_bb0245","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MBC.0b013e32835e98bf","article-title":"P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting","volume":"24","author":"Zoheir","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918302336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918302336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:27:13Z","timestamp":1751448433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918302336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"alternative-id":["S0378111918302336"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.03.007","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}